http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008050363-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e80cf6e56e248a0277fdcc398fb5d8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15e5030d5433c11b74cd245ec5e15ed3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8dd34a02264f4ec04551ff1300e83f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3de5f6e00ced72593c18547573018539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_87433d0eb5f355c31a6d848a8af0c140
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
filingDate 2007-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55206a263947986558a9dceb673f2939
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb920f000aba57dc0c586d65e05ff965
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0db606affa1c4479cd0b1df84926032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5390272b7ca36efa2863f2025120eca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a52d9bd04e5f789280e739a5fbd239b
publicationDate 2008-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2008050363-A3
titleOfInvention Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases
abstract The invention concerns the use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of autoimmune diseases such as multiple sclerosis, and inflammatory bowel diseases such as Crohn's disease or ulcerative colitis.
priorityDate 2006-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9818491-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9600573-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4444757-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9511696-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130571
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600775

Total number of triples: 36.